Antifungal Drugs Market by Infection Type (Superficial Fungal Infection, Systemic Fungal infection), Type (Allylamines, Azoles, Echinocandins), Form, Therapeutic Indications - Global Forecast 2024-2030
The Antifungal Drugs Market size was estimated at USD 14.89 billion in 2023 and expected to reach USD 15.80 billion in 2024, at a CAGR 6.19% to reach USD 22.69 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antifungal Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antifungal Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antifungal Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Becton, Dickinson and Company, bioMérieux SA, Cadila Pharmaceuticals Limited, Cardinal Health, Inc., Cipla, Inc., Enzon Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Hologic, Inc., Johnson & Johnson, Lakewood-Amedex, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Quest Diagnostics Incorporated, SCYNEXIS, Inc., Sigma-Aldrich, Inc., and Sun Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Antifungal Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
Infection Type
Superficial Fungal Infection
Allylamines
Butenafine
Imidazoles
Anidulafungin
Amphotericin B
Ointments
Aspergillosis
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Antifungal Drugs Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antifungal Drugs Market?
- What are the technology trends and regulatory frameworks in the Antifungal Drugs Market?
- What is the market share of the leading vendors in the Antifungal Drugs Market?
- Which modes and strategic moves are suitable for entering the Antifungal Drugs Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Antifungal Drugs Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of fungal infection among population worldwide
- 5.1.1.2. High awareness levels pertaining to myriad fungal infections
- 5.1.1.3. Favorable government approvals for antifungal drugs
- 5.1.2. Restraints
- 5.1.2.1. Continued preference for conventional antifungal drugs
- 5.1.3. Opportunities
- 5.1.3.1. Increased R&D funding and focus on product innovation
- 5.1.3.2. Stategic alliances and partnerships for antifungal drugs
- 5.1.4. Challenges
- 5.1.4.1. Presence of counterfeit drugs and patent expiration of branded drugs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Antifungal Drugs Market, by Infection Type
- 6.1. Introduction
- 6.2. Superficial Fungal Infection
- 6.3. Systemic Fungal infection
- 7. Antifungal Drugs Market, by Type
- 7.1. Introduction
- 7.2. Allylamines
- 7.3.1. Butenafine
- 7.3.2. Naftifine
- 7.3.3. Terbinafine
- 7.3. Azoles
- 7.4.1. Imidazoles
- 7.4.2. Thiazoles
- 7.4.3. Voricanazole
- 7.4. Echinocandins
- 7.5.1. Anidulafungin
- 7.5.2. Caspofungin
- 7.5.3. Micafungin
- 7.5. Polyenes
- 7.6.1. Amphotericin B
- 7.6.2. Candicidin
- 7.6.3. Hamycin
- 7.6.4. Natamycin
- 8. Antifungal Drugs Market, by Form
- 8.1. Introduction
- 8.2. Ointments
- 8.3. Powder
- 8.4. Tablets
- 9. Antifungal Drugs Market, by Therapeutic Indications
- 9.1. Introduction
- 9.2. Aspergillosis
- 9.3. Candidiasis
- 9.4. Dermatophytosis
- 10. Americas Antifungal Drugs Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Antifungal Drugs Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Antifungal Drugs Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. Astellas Pharma Inc.
- 14.1.3. Bayer HealthCare Pharmaceuticals LLC
- 14.1.4. Becton, Dickinson and Company
- 14.1.5. bioMérieux SA
- 14.1.6. Cadila Pharmaceuticals Limited
- 14.1.7. Cardinal Health, Inc.
- 14.1.8. Cipla, Inc.
- 14.1.9. Enzon Pharmaceuticals, Inc.
- 14.1.10. F. Hoffmann-La Roche Ltd.
- 14.1.11. Gilead Sciences, Inc.
- 14.1.12. Hologic, Inc.
- 14.1.13. Johnson & Johnson
- 14.1.14. Lakewood-Amedex, Inc.
- 14.1.15. Merck KGaA
- 14.1.16. Novartis AG
- 14.1.17. Pfizer, Inc.
- 14.1.18. Quest Diagnostics Incorporated
- 14.1.19. SCYNEXIS, Inc.
- 14.1.20. Sigma-Aldrich, Inc.
- 14.1.21. Sun Pharmaceutical Industries Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ANTIFUNGAL DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. ANTIFUNGAL DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANTIFUNGAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANTIFUNGAL DRUGS MARKET DYNAMICS
- FIGURE 7. ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2030 (%)
- FIGURE 8. ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
- FIGURE 12. ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2023 VS 2030 (%)
- FIGURE 14. ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ANTIFUNGAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ANTIFUNGAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook